New York State Cannabis Testing & Innovation Lab
DOPE DIAGNOSTICS
New York State Cannabis Testing & Innovation Lab
New York State Cannabis Sampling Firm Permit #OCM-CSF-00010.
New York State Cannabis Laboratory Permit #OCM-CPL-2022-021.
Dope Diagnostics
A DIVERSE TEAM BEHIND AN INNOVATIVE BUSINESS.
Dope Diagnostics was born when our professionally and culturally diverse team learned that we all shared a concern for the integrity of the cannabis products being brought into people’s homes.
We believe consumers shouldn’t have to question the quality of the cannabis they put in their bodies. An analytical lab using science and digital innovation can provide the trust and reliability missing in the marketplace.
We come from different disciplines; science, tech, legal, finance, creative, and marketing, with a common belief that consumer rights and transparency in the cannabis industry is attainable.
New York’s historically stringent standards mean it is the best place for our lab to launch. The New York program also lends itself to our other priority; social equity in the cannabis industry, investing in marginalized communities most harmed by the prohibition of cannabis.
The Dope Diagnostics mission is using scientific analytics and shared digital access to deliver integrity, accuracy, and innovation to the cannabis industry.
Our Mission
The Dope Diagnostics mission is using scientific analytics and shared digital access to deliver integrity, accuracy, and innovation to the cannabis industry.
The Challenge
Analytics Short Fall
New York’s cannabis testing regulations mirror standards set by federal agencies for food and drugs. This creates a high barrier to entry and a shortage of analytical testing facilities.
• Cannabinoid Hemp must be tested by an NYS Ag & Markets approved “Identified Hemp Testing Laboratory,” which has an ISO 17025 Certification number. Agriculture and Markets (ny.gov)
• Adult-Use and Medical Cannabis is required to be tested by NYS Office of Cannabis Management permitted Cannabis Laboratories. Office of Cannabis Management (ny.gov)
A scarcity of quality laboratories to handle the analytics demand leads to inconsistent test results, rushed reports with limited data and unclear Certificates of Analysis.
Consumers confused by unreliable information lose trust in Cannabis products. Growers and manufacturers without accurate in-depth analytics have a limited ability to innovate quickly and are unable to meet changing market demand.
The Way Out
Dope Diagnostics will be a 5,000+ square foot facility located at the Hudson Valley iCampus in the hamlet of Pearl River in Rockland County, NY planning to be operational in 2023.
The Effect
An Unsuccessful Marketplace
Dope Diagnostics
The Solution
Inauthentic analytics with no visibility into market demand
Crop
Increase return-on-investment (ROI) through seed-to-sale consulting and harvest predictability.
Current extraction methods leave high levels of residual agents
Processor
Ensure safety and regulatory compliance and optimize extraction methods.
Consumer confusion with product specifications
Retailer
Educate and consult, helping customers make intelligent purchasing decisions.
Lack of certification allows substandard brands to prosper
Brand
Authenticate with a reliable seal of approval and provide access to data and analytics.
Why New York?
And Why Now?
*Forbes 3/21 **Castetter Cannabis Group 11/21
Why New York?
And Why Now?
Our Team
CRAIG BESNOY ESQ
CEO and General Counsel
SHEILA E DENNIS, MS
Head of Lab Operations
ALDOUS LLOYD
Agricultural Advisor
JILL GORDON
Head of Business Development
KATE HRUBY
Regulatory Operations
EMMET A. DENNIS JR
Branding Advisor and Investor
AUBREY FLYNN
Marketing Strategy Advisor
KAELAN CASTETTER
New York Canna Industry Advisor
DANA RADZICKI
New York Analytic Chemistry Cannabis Consultant